Moderna was a major player in the race to develop a vaccine for COVID-19. Now, according to a recent Engadget article, the company is using the same mRNA-based technology to combat the seasonal flu. The company announced last Wednesday that it has begun human trials as part of a Phase 1/2 clinical study.
Moderna’s mRNA Flu Vaccine Enters Trials
The same technology behind the COVID-19 vaccine looks to take on normal seasonal bugs next.
Jul 16, 2021
Recommended
Recommended
INTRODUCING! The Latest Trends for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
Read More
